本セッションは、ハイブリッド(現地&オンライン)セッションです。
This session will be held in a hybrid format (onsite and online).
※Please note that the program is subject to change without prior notice. We appreciate your understanding.
Organizer: Office of the City of Yokohama Representative to the Americas
Venue: Tech Hub Yokohama (Landmark Tower, 2-2-1 Minatomirai, Nishi-ku, Yokohama)
Language: English
*同時翻訳ツールあり(テキストのみ)| Simultaneous translation tool available (text only)
Description:
The United States and Japan are among the world’s leading life sciences markets, but startups seeking to enter each other’s ecosystems must navigate significant differences in fundraising, regulatory approval, clinical development, pricing, reimbursement, and market access.
This session will bring together investors, legal and regulatory experts, and market access specialists from Japan and the United States to discuss how life sciences startups can develop integrated cross-border strategies. The panel will explore how regulatory and clinical considerations affect fundraising and investment decisions, the differences between the U.S. and Japanese healthcare and market structures, and the timing, preparation, and partnerships required for successful market entry.
Held one week before BioJapan 2026 in Yokohama, the session will also promote information exchange, networking, investment, and business collaboration between the U.S. and Japanese life sciences ecosystems.
Speakers:
—
■ オンライン参加方法 | How to join the session online